Wolf Group Capital Advisors Bristol Myers Squibb CO Transaction History

Wolf Group Capital Advisors

$234 Million
Q3 2024

A detailed history of Wolf Group Capital Advisors transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wolf Group Capital Advisors holds 23,467 shares of BMY stock, worth $1.38 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

23,467

Previous 25,098 6.5%

Holding current value

$1.38 Million

Previous $1.04 Million 16.51%

% of portfolio

0.52%

Previous 0.42%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$39.66 - $51.75 $64,685 - $84,404	-1,631 Reduced 6.5%	23,467 $1.21 Million
Q2 2024 Jul 30, 2024	BUY	$40.25 - $52.99 $65,647 - $86,426	1,631 Added 6.95%	25,098 $1.04 Million
Q4 2023 Jan 22, 2024	BUY	$48.48 - $57.85 $12,604 - $15,041	260 Added 1.12%	23,467 $1.2 Million
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $5,499 - $6,149	-95 Reduced 0.41%	23,207 $1.35 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $25,165 - $27,942	-395 Reduced 1.67%	23,302 $1.49 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $182,345 - $206,820	-2,775 Reduced 10.48%	23,697 $1.64 Million
Q4 2022 Feb 06, 2023	SELL	$68.48 - $81.09 $131,344 - $155,530	-1,918 Reduced 6.76%	26,472 $1.9 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $2 - $1,536	-20 Reduced 0.07%	28,390 $2.02 Million
Q2 2022 Jul 20, 2022	SELL	$72.62 - $79.98 $275,956 - $303,924	-3,800 Reduced 11.8%	28,410 $2.19 Million
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $4.05 Million - $4.85 Million	-65,815 Reduced 67.14%	32,210 $2.35 Million
Q4 2021 Jan 19, 2022	BUY	$53.63 - $62.52 $3.53 Million - $4.12 Million	65,912 Added 205.25%	98,025 $6.11 Million
Q3 2021 Oct 20, 2021	SELL	$59.17 - $69.31 $31,241 - $36,595	-528 Reduced 1.62%	32,113 $1.9 Million
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $7,057 - $7,685	114 Added 0.35%	32,641 $2.18 Million
Q1 2021 Apr 19, 2021	BUY	$59.34 - $66.74 $55,245 - $62,134	931 Added 2.95%	32,527 $2.05 Million
Q4 2020 Jan 29, 2021	SELL	$57.74 - $65.43 $6,178 - $7,001	-107 Reduced 0.34%	31,596 $1.96 Million
Q3 2020 Oct 30, 2020	BUY	$57.43 - $63.64 $1,895 - $2,100	33 Added 0.1%	31,703 $1.91 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $99,717 - $116,579	1,819 Added 6.09%	31,670 $1.86 Million
Q1 2020 Apr 16, 2020	BUY	$46.4 - $67.43 $54,520 - $79,230	1,175 Added 4.1%	29,851 $1.66 Million
Q4 2019 Jan 29, 2020	BUY	$49.21 - $64.19 $310,121 - $404,525	6,302 Added 28.17%	28,676 $1.84 Million
Q3 2019 Nov 14, 2019	BUY	$42.77 - $50.71 $718,963 - $852,435	16,810 Added 302.12%	22,374 $1.14 Million
Q2 2019 Jul 17, 2019	BUY	$44.62 - $49.34 $248,265 - $274,527	5,564 New	5,564 $252,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolf Group Capital Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Wolf Group Capital Advisors with notifications on news.

Account

Wolf Group Capital Advisors Bristol Myers Squibb CO Transaction History